You're currently on:
- Home
- Interventional Patient Hygiene
- Antiseptic Body Cleansing Pads
Antiseptic Body Cleansing Pads
PROBLEM: MRSA INFECTION MAY DOUBLE MORTALITY
At risk patients need an effective means of skin decolonisation.
Interventions designed to reduce antibiotic resistance and control MRSA in hospitals are vital to minimise morbidity and mortality due to infections caused by resistant organisms1.
Hospital-acquired infections (HAIs) affect about 1 out of 10 patients and are a cause of significant morbidity and mortality2. Of particular signficance are MRSA HAIs, a leading cause of hospital-acquired infections. Compared with patients with bacteraemia caused by methicillin-susceptible S. aureus, those with MRSA bacteraemia have nearly twice the mortality rate, significantly longer hospital stays, and significantly higher median hospital costs3.
Risk Factors for MRSA colonisation and HAI3
• Prolonged hospital stay
• Exposure to broad-spectrum antimicrobials
• Presence of foreign bodies such as central venous catheters
• Frequent contact with the healthcare system or healthcare personnel
Risk Factors for MRSA colonisation and HAI3
The number of cases of MRSA has been rising sharply—from 2,422 in 1997 in England and Wales, to 7,684 in 2003/4 in England alone. Official figures show that about 15% of reported MRSA cases result in death5.
In the past 10 years, an increase in the prevalence of MRSA infections has been observed in Germany6.Data from 11 German hospitals shows that MRSA patients stay in the hospital 11 days longer, exhibit a 7% greater mortality rate and create significantly higher total costs7.
Costs
Additional cost to one healthcare Trust for care of patients with a healthcare-acquired infection was £3.6 million2.
According to the Ontario Ministry of Health and Long Term Care, MRSA colonisation created an additional cost of €1,112, while managing a patient with MRSA cost an additional €23,800‡,8.
SOLUTION: THE SOLUTION THAT STAYS ON SKIN
2% CHG leave-on solution in a gentle, exfoliating cloth outperforms 4% rinse-off solution1,2.
2% Formula Proven Effective
Antiseptic Body Cleansing Washcloths (2% CHG) have been proven to leave more residual CHG on the skin than 4% solution1,2. One study found that the non-abrasive, polyester cloth “most likely promotes a gentle exfoliation of skin cells that allows for a more thorough antiseptic effect immediately after application. Our rinse-free formula keeps CHG active for 6 hours after application.
No-Rinse vs. Rinse-off CHG
In one study, 2% no-rinse CHG Cloths were shown to improve antiseptic persistence on patients’ skin more than 4% rinse-off solution. Researchers found “…the amount of CHG that remains on the skin after a no-rinse application is significantly higher than a CHG application that is rinsed off. This finding indicates that most of the CHG is likely rinsed off the skin during or after the application of the product, leaving very little CHG on the skin.”
UK Department of Health Rapid Review Panel (RRP)4
Antiseptic Body Cleansing Washcloths:
“Basic research and development, validation and recent in-use evaluations have shown benefits that should be available to National Health Service (NHS) bodies to include as appropriate in their cleaning, hygiene or infection control protocols.” (Level 1 Recommendation)
Society for Health Epidemiology of America (SHEA)
RESULTS: REDUCED RISK OF MRSA BACTERAEMIA
Easy-to-use cloths work against a broad spectrum of organisms1,2
Proven Results Against MRSA, VRE & Acinetobacter
A study using 2% CHG Cloths for daily bedside bathing found the incidence of Acinetobacter was decreased by 84% in the Trauma Intensive Care Unit and by 100%, to 0 incidences, in the Respiratory Intermediate Care Unit3.
In another study, 9-month results for bathing with Antiseptic Body Cleansing Washcloths (2% CHG) found “…bathing MICU (Medical Intensive Care Unit) patients with disposable cloths containing 2% Chlorhexidine Gluconate reduced the microbial density of VRE on patients’ skin”4.
In a 6-year UK study, introduction of Antiseptic Body Cleansing Washcloths in 2007 was associated with a 99% decrease in MRSA bateraemias while reducing MRSA acquisition by 80%5.
Risk Factors for MRSA colonisation and HAI3
The number of cases of MRSA has been rising sharply—from 2,422 in 1997 in England and Wales, to 7,684 in 2003/4 in England alone. Official figures show that about 15% of reported MRSA cases result in death5.
In the past 10 years, an increase in the prevalence of MRSA infections has been observed in Germany. Data from 11 German hospitals shows that MRSA patients stay in the hospital 11 days longer, exhibit a 7% greater mortality rate and create significantly higher total costs7.
A Simple, Effective strategy
“Cleansing patients with chlorhexidine-saturated cloths is a simple, effective strategy to reduce VRE contamination of patients’ skin, the environment and healthcare workers’ hands, and to decrease patient acquisition of VRE.”6
Costs
Additional cost to one healthcare Trust for care of patients with a healthcare-acquired infection was £3.6 million2.
According to the Ontario Ministry of Health and Long Term Care, MRSA colonisation created an additional cost of €1,112, while managing a patient with MRSA cost an additional €23,800‡,8.
Click Below To Purchase
amp;
nbsp;